Jim Simons’s Yarrow Bioscience YARW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.2K | Buy |
466
+120
| +35% | +$3.89K | ﹤0.01% | 3114 |
|
|
2026
Q1 | $10.3K | Buy |
+346
| New | +$10.1K | ﹤0.01% | 3197 |
|
|
2025
Q3 | – | Sell |
-211
| Closed | -$17.4K | – | 3986 |
|
|
2025
Q2 | $17.4K | Sell |
211
-2,092
| -91% | -$136K | ﹤0.01% | 3476 |
|
|
2025
Q1 | $182K | Buy |
2,303
+1,804
| +362% | +$222K | ﹤0.01% | 3093 |
|
|
2024
Q4 | $83.6K | Sell |
499
-1,234
| -71% | -$161K | ﹤0.01% | 3314 |
|
|
2024
Q3 | $163K | Buy |
1,733
+471
| +37% | +$44.6K | ﹤0.01% | 3166 |
|
|
2024
Q2 | $124K | Sell |
1,262
-350
| -22% | -$43.6K | ﹤0.01% | 3144 |
|
|
2024
Q1 | $247K | Buy |
1,612
+684
| +74% | +$73.7K | ﹤0.01% | 3157 |
|
|
2023
Q4 | $108K | Buy |
928
+408
| +78% | +$63.6K | ﹤0.01% | 3289 |
|
|
2023
Q3 | $105K | Sell |
520
-202
| -28% | -$44.1K | ﹤0.01% | 3231 |
|
|
2023
Q2 | $148K | Buy |
722
+210
| +41% | +$55.9K | ﹤0.01% | 3364 |
|
|
2023
Q1 | $79K | Sell |
512
-451
| -47% | -$81K | ﹤0.01% | 3558 |
|
|
2022
Q4 | $130K | Sell |
963
-69
| -7% | -$13.8K | ﹤0.01% | 3552 |
|
|
2022
Q3 | $207K | Sell |
1,032
-12
| -1% | -$3.84K | ﹤0.01% | 3370 |
|
|
2022
Q2 | $365K | Sell |
1,044
-28
| -3% | -$11.7K | ﹤0.01% | 3342 |
|
|
2022
Q1 | $627K | Buy |
1,072
+67
| +7% | +$39.8K | ﹤0.01% | 3037 |
|
|
2021
Q4 | $923K | Sell |
1,005
-378
| -27% | -$406K | ﹤0.01% | 2709 |
|
|
2021
Q3 | $1.73M | Buy |
1,383
+1,038
| +301% | +$2.01M | ﹤0.01% | 2202 |
|
|
2021
Q2 | $1.09M | Buy |
+345
| New | +$1.37M | ﹤0.01% | 2630 |
|
|
2021
Q1 | – | Sell |
-127
| Closed | -$725K | – | 3753 |
|
|
2020
Q4 | $725K | Buy |
+127
| New | +$798K | ﹤0.01% | 2659 |
|
|
2020
Q3 | – | Sell |
-86
| Closed | -$535K | – | 3727 |
|
|
2020
Q2 | $535K | Buy |
+86
| New | +$582K | ﹤0.01% | 2852 |
|
|
2020
Q1 | – | Sell |
-42
| Closed | -$704K | – | 3845 |
|
|
2019
Q4 | $704K | Buy |
42
+7
| +20% | +$117K | ﹤0.01% | 2775 |
|
|
2019
Q3 | $559K | Buy |
35
+4
| +13% | +$64.6K | ﹤0.01% | 2831 |
|
|
2019
Q2 | $659K | Buy |
31
+18
| +138% | +$445K | ﹤0.01% | 2882 |
|
|
2019
Q1 | $373K | Buy |
13
+8
| +160% | +$192K | ﹤0.01% | 3032 |
|
|
2018
Q4 | $81K | Sell |
5
-4
| -44% | -$89.5K | ﹤0.01% | 3254 |
|
|
2018
Q3 | $308K | Buy |
+9
| New | +$278K | ﹤0.01% | 3011 |
|
Other funds holding YARW
LCM
TC
KCA
Jim Simons's YARW Position: Q2 2026 in Review
Jim Simons increased its Yarrow Bioscience (YARW) stake by 35% in Q2 2026, buying an estimated $3.89K and bringing the position to 466 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.
Jim Simons first reported a position in YARW in Q3 2018 and has held it in 27 quarters since. The position peaked at $1.73M in Q3 2021. 41 funds tracked by Wall St. Rank hold YARW as of Q2 2026.
- Jim Simons held 466 shares of Yarrow Bioscience worth $15.2K as of Q2 2026.
- Jim Simons bought 120 Yarrow Bioscience shares in Q2 2026, an estimated $3.89K.
- Yarrow Bioscience made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #3114 holding.
- Jim Simons first reported a position in Yarrow Bioscience in Q3 2018 and has held it in 27 quarters since.
- Jim Simons's Yarrow Bioscience position peaked at $1.73M in Q3 2021.
- 41 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.